Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
IBS is a chronic functional gastrointestinal disorder characterised by recurrent abdominal pain associated with altered bowel habits, typically diagnosed using the Rome IV criteria (symptom onset at least 6 months before diagnosis, with abdominal pain at least 1 day/week in the last 3 months, plus related stool/defecation criteria)
There are no major side effects reported, though patients can experience diarrhea and swelling or redness at the injection site
NO production is known to decrease with aging primarily via decrements in the NOS-dependent pathway (Pourbagher-Shahri et al., 2021
Wegovy is a GLP-1 receptor agonist used for weight management in adults with obesity or overweight with weight-related conditions
US$ 20.42
US$ 28.07
US$ 28.42
-1775582746855.png&w=3840&q=75)
US$ 20.68
